Advertisement
Document › Details
Bruker Corporation. (7/17/19). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA.
Organisation | Bruker Corporation (Nasdaq: BRKR) | |
Group | Bruker (Group) | |
Product | analytical instrument | |
Product 2 | diagnostics (medical/biological) | |
Person | Laukien, Jörg C. (Bruker –201811 Board Member RETIRED 11/18) | |
Person 2 | Laukien, Frank H. (Bruker 201204 President + CEO) | |
Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification. Joerg Laukien retired from the Bruker board of directors effective November 5, 2018. He is the brother of Bruker's President and CEO Frank H. Laukien, who is not selling any shares in this transaction.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.
Contact :
Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: miroslava.minkova@bruker.com
Record changed: 2023-06-05 |
Advertisement
More documents for Bruker (Group)
- [1] Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [2] Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [3] Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich....
- [4] Ion Opticks Pty Ltd.. (12/5/24). "Press Release: IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-quality Proteomic Insights". Melbourne....
- [5] Bruker Corporation. (10/2/24). "Press Release: Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery". Munich....
- [6] Bruker Corporation. (8/23/24). "Press Release: Bruker Corporation to Present at Upcoming Investor Conferences". Billerica, MA....
- [7] Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix"....
- [8] Bruker Corporation. (7/2/24). "Press Release: Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin". Berlin....
- [9] Bremen, Senatskanzlei. (5/16/24). "Pressemitteilung: Massenspektrometrie aus Bremen – Bruker Daltonics erweitert Produktion mit zweitem Standort in der Hansestadt". Bremen....
- [10] NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top